Author Guidelines

AUTHOR GUIDELINES

International Journal of Drug Regulatory Affairs (IJDRA) publishes Reviews, Research papers and Short communications/Technical notes. Manuscripts will be reviewed by members of the editorial board, whose opinions will form the basis of the final decision by the editor. It is recommended that an English check of the manuscript by a competent and knowledgeable native speaker be completed before submission. Failure to follow them may result in papers being delayed or rejected.

BEFORE YOU BEGIN: All submitted manuscripts should contain original work neither published previously not under consideration for publication elsewhere. Articles from any part of the world are accepted provided submitted in English language only. It is necessary that authors prepare their manuscripts according to the instructions. Effectiveness of the peer review process will greatly depends upon the care used by the authors in preparing the manuscripts.

PLAGIARISM: Original Research should be allowed to publish in the Journal & we use "VIPER Anti-Plagiarism Scanner" to detect the Plagiarism in the text. Viper is a program that will scan for Plagiarism in any text.

TYPES OF MANUSCRIPTS

Research Article: Research papers should contain unpublished results of original research, which must be presented in sufficient detail to ensure the reproducibility of the described experiments and should present new experimental studies in elaborate form that constitute a significant contribution to knowledge. They may be up to 5-20 pages.

Review Article: Review articles are concise and critical surveys of novel accomplishments in the author's research field and should bring up the most important current topics or present interpretative and critical accounts, but not simple compilation, on subjects of general interest. The work need not be complete; however, supporting experimental data must be described. They should be around 4-18 pages.

Case Study: A case study describes a typical situation or problem. It is a written account, ideally from the decision-maker's point of view, of an undertaking as it actually occurred. The outcome of the situation described should generally be measured against selected criteria or benchmarks, and its presentation should contribute in one way or another to best practices and excellence. Finally, case studies offer an opportunity to relate real experience to the principles and practices of Pharmacy. In general, they should be around 2-8 pages.

SUBMITTING PAPERS TO IJDRA

Manuscripts are accepted on the understanding that the authors have obtained the necessary authority for publication. Manuscripts with multi-authors imply the consent of each of the authors. The publisher will presume that the corresponding author has specifically obtained the approval of all other co-authors to submit the article to IJDRA. Submission of an article to IJDRA is understood to imply that it has not been either published or not being considered for publication elsewhere. Manuscripts should be neatly typed, single lines spaced throughout, including tables, on pages of uniform size. On acceptance authors are asked to fill the copyright transfer form that is available on journal’s web site.

Manuscript can be submitted online after Register in IJDRA

Any Queries/Suggestion contact via Email: info@ijdra.Com ;editorijdra@gmail.com

MANUSCRIPTS PREPARATIONS

Research Article: File should contains Manuscript Title, Abstract, Introduction, Materials and Methods, Results, Discussion or Results and Discussion, Acknowledgment, Conflicts of interest, & References.

Review Article: not contains Materials and Methods and Results other heading are same as above.

Case Study: Introduction, Case description, Discussion and Evaluation, Conclusions.

File Formats: Submit MS word files, with Figure, Photos, Graphs and/ tables electronically embedded within the text of the document with A4 page, & 0.7'' margins on all sides (Top, Bottom, Left & Right). 

Manuscript Title: Top of paper, Times New Roman; Fonts all caps, bold, 10 points.

Author Names: Last name, followed full first name, corresponding author of the manuscript must be marked with an asterisk (*) and should be listed first, font: bold, 10 points.

Institution Name: Institution addresses 10 points font size.

E-mail: Email of corresponding author, Times New Roman, Italic, 10 points font size.

ABSTRACT

Times New Roman, 9 points font size, with single line spacing.

Research & Reviews articles should include structured abstracts of 150 to 250 words.

Research Article: Objective(s), Design, Intervention(s), Main outcome measure(s), Results, Conclusion, Keywords.

Case Study: 100 words, Introduction, Case description, Discussion and Evaluation, Conclusions.

Reviews Article: Objective(s), Data sources Study selection, summary of contents of the article, Conclusion, Keywords.

TEXT

Times New Roman, 10 points font size, text of the document with single line spacing. Use 6 point spacing Before & 0 points after Paragraph.

INTRODUCTION

Provide a context or background for the study. Explain the objective of research, or hypothesis used. Provide literature with references related to your research. Provide only directly pertinent references, and do not include data or conclusions from the work being reported.

MATERIAL AND METHODS

The Methods section should include only information that was available at the time the plan or protocol for the study was being written; all information obtained during the study belongs in the Results section. Author should provide appropriate reference for every method used in research work.

RESULT & DISCUSSION

RESULTS

Present your results in logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Do not repeat all the data in the tables or illustrations in the text; emphasize or summarize only the most important observations. When data are summarized in the Results section, give numeric results not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated, and specify the statistical methods used to analyze them. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables.

DISCUSSION

Emphasize the novel and important aspects of the study and the conclusions that follow from them in the context of the totality of the best available evidence. Do not repeat in detail data or other information given in the Introduction or the Results section. For experimental studies, it is useful to begin the discussion by briefly summarizing the main findings, then explore possible mechanisms or explanations for these findings, compare and contrast the results with other relevant studies, state the limitations of the study, and explore the implications of the findings for future research and for clinical practice.

CONCLUSIONS

Link the conclusions with the goals of the study but avoid unqualified statements and conclusions not adequately supported by the data. Avoid claiming priority or alluding to work that has not been completed.

States new hypotheses when warranted but label them clearly as such.

Tables, Graphs and figures: Should be appropriately inserted within text.

ACKNOWLEDGMENTS

Contributors who do not meet the criteria for authorship should be listed under acknowledgments along with a description of their specific contributions. Examples include individuals providing technical or writing assistance, or a department chair providing general support.

CONFLICTS OF INTEREST

Authors should disclose any personal or financial relationships that could be viewed as potential conflicts of interest in relation to the publication on manuscript file just before references section.

REFERENCES

Use Vancouver style in-text citations and a Reference List at the end of your document. Citations within the text of your paper are identified with a number in round brackets.

Example: Jones (8) has argued that…

When multiple references are cited together, use a hyphen to indicate a series of inclusive numbers. Use commas to indicate a series of non-inclusive numbers. A citation with these references (4,5,6,7,14,19) is abbreviated to (4-7,14,19).

Journals:

  1. Gupta AK, Dhakar RC, Siddiqui AW, Maurya SD. Interpenetrating polymeric network hydrogel for stomach-specific drug delivery of clarithromycin: Preparation and evaluation. Asian Journal of Pharmaceutics. 2010; 4(4):184-9.
  2. Dhakar RC. Non-Invasive systemic drug delivery via Nasal route: A Pharmaceutical Review. AJPSP. 2011; 2(1):114-44.
  3. Maurya SD, Dhakar RC, Gupta AK, Singh RD. Formulation and Evaluation of Ethosomal Drug Delivery System of Stavudine. IJPER. 2010; 44(1):102-8.

Case Study:

  1. Merritt L. Case reports: an important contribution to chiropractic literature. J Can Chiropr Assoc 2007; 51(2):72–4.
  2. Gleberzon BJ. A peer-reviewer’s plea. J Can Chirop Assoc. 2006; 50(2):107.

Books: Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy. 3rd ed. Mumbai: Varghese Publishing House; 1987. p. 182-4.

ARTICLE PROCESSING CHARGES (APC) AND WAIVER POLICY:

ARTICLE PROCESSING CHARGES:

IJDRA is an open access journal with no subscription or Article submission charges, a fee is payable by the author or research funder to cover the costs associated with publication. This ensures your article will be immediately and permanently free to access by everyone.

Publishing an article in this Journal requires Article Processing Charges that will be billed to the submitting author following the acceptance of an article for publication. Apart from these Article Process Charges, there are no submission charges, page charges, or color charges. The fees to be paid following the acceptance of an article are indicated below:

The publication fee for article is - 

1500 INR/article from Indian Authors

USD 30/article from Authors from Low-Income Countries.

USD 40/article from Authors from Low-Middle Income Countries.

USD 60/article from Authors from Upper-Middle-Income Countries

USD 100/article from Authors from High-Income Countries.

(No other hidden charges)

WAIVER POLICY: 

We provide a waiver of Article Processing Charges to authors based on country classification by World Bank

We can also waive 100% in some special condition depend on if there is no funding and author not able to charge any fees. In order to apply for a waiver, please request one before submitting your manuscript by sending an email to editorijdra@gmail.com

You can find more details about the list of country as per classification of World Bank.

Waiver Application Process:

  • Author(s) requesting for waiver must strongly demonstrate why their waiver applications should be granted.
  • Request for a waiver must be sent same day a manuscript is submitted to editor.jddt@gmail.com.
  • We reserve the right to approve or reject a waiver application. Waiver decision will be communicated to the corresponding author within one week after the application is received.
  • Waiver request should contain the following information:

    Manuscript ID and Title

    Corresponding Author Affiliation and Country

    List co-author(s) Affiliation(s) and Country

    Reason for requesting a waiver for processing fees

Account details to Transfer fees:

Account Name: JITENDRA KUMAR BADJATYA

Account No. 20003834671

Bank Name: State Bank of India

IFSC Code: SBIN0009316

Branch code: 09316

Address: SME Branch, Govind Ashram, I floor, GT Road, Shahdara, Delhi, India-110032.

Modes of Payments: Credit/Debit card/DD/Cheque /Online Banking

Note: It is compulsory to send payment details [i.e. soft copy of cash receipt/ DD details / Cheque Details / Online Transaction/ Western Union/other mode] to editorijdra@gmail.com

CONTACT DETAILS:

International Journal of Drug Regulatory Affairs (IJDRA)
1/7756, East Gorakh Park, Shahdara, Delhi, India-110032
Email: info@ijdra.com; editorijdra@gmail.com
(M) +91-7096160846